Skip to main content

Market Overview

Oppenheimer Maintains Outperform on Evofem Biosciences, Raises Price Target to $25


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for EVFM

Jun 2021HC Wainwright & Co.MaintainsBuy
Mar 2021HC Wainwright & Co.MaintainsBuy
Oct 2020StifelInitiates Coverage OnBuy

View More Analyst Ratings for EVFM
View the Latest Analyst Ratings


Related Articles (EVFM)

Posted-In: News Price Target Analyst Ratings

Latest Ratings

ZIWolfe ResearchMaintains75.0
TBIOSVB LeerinkMaintains38.0
NEWTRaymond JamesDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at